Cellectis SA
SWB:ZVAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cellectis SA
SWB:ZVAA
|
FR |
|
I
|
Innovative Industrial Properties Inc
SWB:1IK
|
US |
|
E
|
Enphase Energy Inc
SWB:E0P
|
US |
|
BYD Co Ltd
SZSE:002594
|
CN |
|
B
|
BCE Inc
XBER:BCE1
|
CA |
|
A
|
Avolta AG
XMUN:D2J
|
CH |
|
W
|
Wolverine World Wide Inc
F:WW4
|
US |
|
Embotelladora Andina SA
NYSE:AKO.B
|
CL |
|
T
|
Tyson Foods Inc
F:TF7A
|
US |
|
Caesars Entertainment Inc
LSE:0A78
|
US |
|
Smith & Wesson Brands Inc
NASDAQ:SWBI
|
US |
|
A
|
Air Products and Chemicals Inc
XMUN:AP3
|
US |
|
S
|
Smith & Wesson Brands Inc
F:SWS
|
US |
|
Dexcom Inc
XETRA:DC4
|
US |
|
Cellectis SA
PAR:ALCLS
|
FR |
Bankruptcy Probability
Cellectis SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cellectis SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Cellectis SA
PAR:ALCLS
|
218.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cellectis SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cellectis SA has total debt of 101.7m USD. This includes both short-term (0 USD) and long-term (101.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
